Minichromosome maintenance protein in myxofibrosarcoma
Sington, James D. Freeman, Alex Morris, Lesley S. Vowler, Sarah L. Arch, Barbara N. Fisher, Cyril Coleman, Nicholas
Sington, James D.
Freeman, Alex
Morris, Lesley S.
Vowler, Sarah L.
Arch, Barbara N.
Fisher, Cyril
Coleman, Nicholas
Advisors
Editors
Other Contributors
EPub Date
Publication Date
2004-02-01
Submitted Date
Collections
Other Titles
Abstract
Histopathological assessment of myxofibrosarcoma may be difficult, especially on the basis of a small core biopsy, which enables only a crude evaluation of grade and prognosis. Hypothesis - that determination of cell cycle state may assist in the diagnostic assessment of myxofibrosarcoma. 51 cases of high-grade (n=20), intermediate-grade (n=21), and low-grade (n=10) myxofibrosarcomas were studied, as well as nine cases of benign myxoma. Cell cycle state within tumors was determined by immunostaining for the recently described marker minichromosome maintenance protein 2 (MCM2), together with Ki67. Labelling indices for both markers were correlated with tumor grade, mitotic index, and time to first recurrence. The MCM2 labelling indices were significantly higher than the Ki-67 labelling indices. Both indices showed a significant correlation with the mitotic index and both showed significant increases with increasing grade of myxofibrosarcoma. The MCM2 labelling index (but not the Ki67 labelling index) showed a significant inverse exponential correlation with the time to first recurrence. Myxoid and cellular areas showed no difference in the MCM2 and Ki-67 labeling index, suggesting that clinically useful information could be obtained from any component of a myxofibrosarcoma sampled in a needle biopsy and/or cytological specimen. We therefore suggest that assessment of cell cycle state may be a useful diagnostic adjunct in the histopathological assessment of myxofibrosarcoma, by enabling more accurate determination of grade and prediction of outcome.
Citation
Modern Pathology, 17(2), 2004, pp. 235-240
Publisher
Nature
Journal
Modern Pathology
Research Unit
DOI
10.1038/modpathol.3800044
PubMed ID
PubMed Central ID
Type
Article
Language
en
Description
This article is not available from CheserRep. The full-text can be accessed at http://www.nature.com/modpathol/journal/v17/n2/full/3800044a.html
Series/Report no.
ISSN
0893-3952
1530-0285
1530-0285
EISSN
ISBN
ISMN
Gov't Doc
Test Link
Sponsors
This article was submitted to the RAE2008 for the University of Chester - Allied Health Professions and Studies.